Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.2M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
44.9M
-
Shares change
-
+1.41M
-
Total reported value, excl. options
-
$238M
-
Value change
-
+$6.93M
-
Put/Call ratio
-
1.06
-
Number of buys
-
61
-
Number of sells
-
-50
-
Price
-
$5.31
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q1 2023
146 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q1 2023.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.9M shares
of 92.2M outstanding shares and own 48.67% of the company stock.
Largest 10 shareholders include PFM Health Sciences, LP (5.01M shares), BlackRock Inc. (4.75M shares), STATE STREET CORP (3.36M shares), Avidity Partners Management LP (2.76M shares), Rokos Capital Management LLP (2.75M shares), BANK OF AMERICA CORP /DE/ (2.63M shares), VANGUARD GROUP INC (2.61M shares), Elmwood Wealth Management, Inc. (2.36M shares), PICTET ASSET MANAGEMENT SA (2.07M shares), and FMR LLC (1.44M shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.